These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 28502470)
1. Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma. Wang S; Reinhard S; Li C; Qian M; Jiang H; Du Y; Lächelt U; Lu W; Wagner E; Huang R Mol Ther; 2017 Jul; 25(7):1556-1566. PubMed ID: 28502470 [TBL] [Abstract][Full Text] [Related]
2. A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma. Lu L; Chen H; Wang L; Zhao L; Cheng Y; Wang A; Wang F; Zhang X Int J Nanomedicine; 2020; 15():8875-8892. PubMed ID: 33209022 [TBL] [Abstract][Full Text] [Related]
3. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting. Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728 [TBL] [Abstract][Full Text] [Related]
4. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333 [TBL] [Abstract][Full Text] [Related]
5. Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system. Yao H; Wang K; Wang Y; Wang S; Li J; Lou J; Ye L; Yan X; Lu W; Huang R Biomaterials; 2015 Jan; 37():345-52. PubMed ID: 25453963 [TBL] [Abstract][Full Text] [Related]
6. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment. Gao S; Tian H; Xing Z; Zhang D; Guo Y; Guo Z; Zhu X; Chen X J Control Release; 2016 Dec; 243():357-369. PubMed ID: 27794494 [TBL] [Abstract][Full Text] [Related]
7. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
8. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy. Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845 [TBL] [Abstract][Full Text] [Related]
9. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198 [TBL] [Abstract][Full Text] [Related]
10. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats. Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664 [TBL] [Abstract][Full Text] [Related]
11. iRGD-mediated core-shell nanoparticles loading carmustine and O Liu C; Yao S; Li X; Wang F; Jiang Y J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474 [TBL] [Abstract][Full Text] [Related]
12. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
13. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery. Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308 [TBL] [Abstract][Full Text] [Related]
15. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer. Gao S; Li J; Jiang C; Hong B; Hao B Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138 [TBL] [Abstract][Full Text] [Related]
17. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Pang L; Qin J; Han L; Zhao W; Liang J; Xie Z; Yang P; Wang J Oncotarget; 2016 Jun; 7(24):37081-37091. PubMed ID: 27213597 [TBL] [Abstract][Full Text] [Related]
18. I6P7 peptide modified superparamagnetic iron oxide nanoparticles for magnetic resonance imaging detection of low-grade brain gliomas. Tan J; Sun W; Lu L; Xiao Z; Wei H; Shi W; Wang Y; Han S; Shuai X J Mater Chem B; 2019 Oct; 7(40):6139-6147. PubMed ID: 31553351 [TBL] [Abstract][Full Text] [Related]
19. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
20. H Zhou M; Jiang N; Fan J; Fu S; Luo H; Su P; Zhang M; Shi H; Zeng J; Huang Y; Li Y; Shen H; Zhang A; Li R J Control Release; 2019 Sep; 310():24-35. PubMed ID: 31404556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]